This is a Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Banfieldbio Inc., a for-profit manufacturer of pest management technologies. The contract, valued at $1,929,600.00, is for the purchase of AGO TRAP AND REPLACEMENT PARTS. Banfieldbio Inc. has previously received federal contracts and grants from agencies such as the U.S. Department of Agriculture (USDA) and the Department of the Army to develop and test innovative pest control solutions,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to BanfieldBio Inc., a for-profit manufacturer, to provide AGO mosquito trap ancillary supplies. The contract, valued at $535,837.11, has an April 2017 completion date and did not have a set-aside designation. BanfieldBio is a technology research company that develops pest management solutions, including trap components, repellents, and landscape treatments, through...
This is a $230,817.53 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Connecticut Agricultural Experiment Station (CAES), a state government research entity. The contract is for the evaluation of the efficacy of fall application of synthetic versus natural acaricides (pesticides that kill ticks and mites). This contract does not have a set-aside designation. CAES, the prime contractor, has a history of receiving federal grants and...
This is a firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced bait to control immature Ixodes scapularis ticks in rodents. The contract has a total ceiling value of $249,940.00 and a completion date of September 23, 2024. Genesis Laboratories has previously received multiple federal contracts from the CDC for vector-borne disease research...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $257,036.00 firm-fixed-price contract to the Connecticut Agricultural Experimental Station (CAES), a state government research entity, to conduct oral delivery of the acaricide (pesticide that kills ticks and mites) moxidectin to white-tailed deer populations. This effort aims to manage the vector tick Amblyomma americanum, which transmits pathogens. The contract, which has no set-aside designation, runs through September 27,...
This is a $620,310.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Genesis Laboratories, Inc., a for-profit subchapter S corporation, to conduct a field trial of fipronil-laced oral bait. The contract, which has an ultimate completion date of August 24, 2026, is intended to support the CDC's vector-borne disease program by controlling tick populations and reducing Lyme disease incidence. Genesis Laboratories has previously conducted...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Rentokil North America, Inc. for vector control trap services. The $4,860,483.60 Firm Fixed Price contract has an ultimate completion date of April 25, 2017 and was awarded on September 26, 2016. The award was not set aside for any specific business type. Rentokil North America, Inc. is a for-profit pest control services company that has extensive experience providing integrated pest management...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price definitive contract to Inc. T.erry L. Schulze, Phd, a for-profit S-corporation, for tick management services. The contract, valued at $97,035.00, will run from September 26, 2023 to March 31, 2025, and will involve tick habitat management, tick-borne disease management feasibility studies, and evaluations of acaricide application methods for the CDC's Pittsburgh office. This award is...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $220,000 firm fixed-price purchase order to the Connecticut Agricultural Experimental Station to conduct research on the evaluation of fall and spring acaricide (pesticide) applications to suppress host-seeking Ixodes scapularis (blacklegged) ticks. The research aims to clarify the value of fall acaricide applications in controlling Ixodes scapularis ticks on residential properties, which can...
This is a 2020 contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to Genesis Laboratories, Inc., a for-profit subchapter S corporation. The $149,147 firm fixed-price contract is for products and services related to vector-borne disease research and prevention, specifically controlling tick populations and reducing Lyme disease incidence. Under this definitive contract, Genesis Laboratories will provide fipronil-laced...